Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:06896's Gross Margin % is ranked better than 88.18% of 939
companies
in the Drug Manufacturers industry
Industry Median: 48.55
vs HKSE:06896: 75.24
Golden Throat Holdings Group Co had a gross margin of 75.43% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Golden Throat Holdings Group Co (HKSE:06896) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Golden Throat Holdings Group Co had a gross margin of 75.43% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Golden Throat Holdings Group Co Gross Margin % Related Terms
Golden Throat Holdings Group Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Golden Throat Holdings Group Co Gross Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Golden Throat Holdings Group Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Golden Throat Holdings Group Co Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Golden Throat Holdings Group Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Golden Throat Holdings Group Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Golden Throat Holdings Group Co (HKSE:06896) has a Gross Margin % of 75.43% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Golden Throat Holdings Group Co and its competitors. This is near median its historical median of 73.10. Over the past decade, Golden Throat Holdings Group Co's Gross Margin % has ranged from 69.80 to 76.01. According to the industry distribution chart, Golden Throat Holdings Group Co ranks #111 out of 939 companies in the Drug Manufacturers industry, placing it in the top 11.8%.
Is Golden Throat Holdings Group Co's Gross Margin % too high?
Golden Throat Holdings Group Co's current Gross Margin % of 75.43% is near median its 10-year median of 73.10. Over the past 10 years, this metric has ranged from a low of 69.80 to a high of 76.01. The Drug Manufacturers industry median Gross Margin % is 48.55. Golden Throat Holdings Group Co's value of 75.43% is 55.4% above this industry median. Based on the distribution chart, Golden Throat Holdings Group Co ranks #111 out of 939 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Golden Throat Holdings Group Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Golden Throat Holdings Group Co's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Golden Throat Holdings Group Co ranks #111 out of 939 companies for Gross Margin %. This places Golden Throat Holdings Group Co in the top 12% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.55. Golden Throat Holdings Group Co's value of 75.43% is 55.4% above this benchmark. Historically, Golden Throat Holdings Group Co's own Gross Margin % has ranged from 69.80 to 76.01 over the past decade. While the company's 10-year median is 73.10 vs. the industry median of 48.55, Golden Throat Holdings Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.55, based on 939 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Golden Throat Holdings Group Co's current Gross Margin % of 75.43% is 55.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Golden Throat Holdings Group Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Golden Throat Holdings Group Co's current Gross Margin % is 75.43%, which is near median its own 10-year median of 73.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Golden Throat Holdings Group Co stock overvalued right now?
Based on GuruFocus' analysis, Golden Throat Holdings Group Co (HKSE:06896) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$2.98, compared to a current price of HK$2.28 — trading 23.7% below its estimated fair value. The current Gross Margin % is 75.43%, which is near median its 10-year median of 73.10 and 55.4% above the Drug Manufacturers industry median of 48.55. Golden Throat Holdings Group Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Golden Throat Holdings Group Co (HKSE:06896), the current Gross Margin % is 75.43% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Golden Throat Holdings Group Co (HKSE:06896) Overvalued in 2026?
Based on GuruFocus' analysis, Golden Throat Holdings Group Co stock appears to be undervalued.
The current stock price of HK$2.28 is trading 23.7% below its estimated GF Value™ of HK$2.98.
GuruFocus considers Golden Throat Holdings Group Co to be Modestly Undervalued.
Key valuation signals for HKSE:06896:
Gross Margin %: 75.43% (near median its 10-year median of 73.10)
GF Value™: HK$2.98 vs. price of HK$2.28 (23.7% below fair value)
Industry Position: 55.4% above the Drug Manufacturers median (#111 of 939)
No single metric tells the full story. See the HKSE:06896 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Golden Throat Holdings Group Co Ltd is an investment holding company. Through its subsidiaries, the company is engaged in the manufacture and sale of pharmaceuticals, healthcare food and other products. The compqny manufactures and sells lozenges and other pharmaceutical and food products. The key products of the group that derives revenue for the group are Golden Throat Lozenges (OTC), Golden Throat Lozenge Series products and other products. The group derives majority of its revenue from Mainland China.
83GF Score
Get the complete analysis for HKSE:06896
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06896 has been successfully added to your 
